RAD51C and triple-negative breast carcinoma: Pathogenic RAD51C variants have previously also been linked particularly to ER-negative and triple-negative breast cancer subtypes [29,30], but all six identified carriers from the unselected cohort turned out to be ER- and PR-positive.